Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India | Zendy

Manju Bala | Zendy; Vikram Singh | Zendy; Aradhana Bhargava | Zendy; Monika Kakran | Zendy; Naveen Chandra Joshi | Zendy; Ravi Bhatnagar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India

Author(s) -

Manju Bala,

Vikram Singh,

Aradhana Bhargava,

Monika Kakran,

Naveen Chandra Joshi,

Ravi Bhatnagar

Publication year - 2016

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01907-16

Subject(s) - neisseria gonorrhoeae , gentamicin , microbiology and biotechnology , multiple drug resistance , biology , neisseriaceae , antibiotics

Antimicrobial susceptibility testing of 258 Neisseria gonorrhoeae isolates by Etest determined that 60.1% were multidrug resistant (MDR), while 5% of the strains had decreased susceptibility to currently recommended extended-spectrum cephalosporins (ESCs). Among these, 84.5% of MDR strains and 76.9% of strains that had decreased susceptibility to ESCs were susceptible to gentamicin. No MDR isolate was resistant to gentamicin. These in vitro results suggest that gentamicin might be an effective treatment option for the MDR strains and in dual therapy for gonorrhea. However, further research regarding the clinical treatment outcomes is essential.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research